Zdrowie i gospodarka · 28/05/2013

FDA to Host Public Workshop on Opioid Conversion Clinical Development Programs and Request for Comments

The US Food and Drug Administration (FDA) is hosting a public workshop to discuss its clinical development programs for converting opioids to safer alternatives, and is seeking public comments on the proposal